Amy Rosenbaum, PA-C

Amy Rosenbaum practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Amy Rosenbaum's NPI, 1013459478, was assigned on November 15, 2016. Amy Rosenbaum holds California license 53998.

Amy Rosenbaum's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Amy Rosenbaum's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Amy Rosenbaum is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Amy Rosenbaum to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amy Rosenbaum practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Amy Rosenbaum's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Amy Rosenbaum is licensed in California.

Dmand AI lists acute skin infection, anxiety, asthma, carpal tunnel syndrome, depression, fibromyalgia and chronic pain, lower back pain and osteoporosis among the conditions Amy Rosenbaum treats.

CMS data shows 326 Medicare services from Amy Rosenbaum across 6 procedure codes in 2024, for 123 Medicare patients. Medicare paid $15,717 for them. Every service was in an office.

CMS counts 123 Medicare patients who saw Amy Rosenbaum in 2024. The largest group is 65 to 74, with 63 patients. 60% of them have high blood pressure, and 54% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Amy Rosenbaum's median patient age at 71, with 76% women.

In 2024, Amy Rosenbaum wrote 1,932 Medicare Part D claims for 220 patients. 82% of them were for generic drugs. CMS names the drug for 1,490 of them, across 46 drugs with 11 or more claims each, at $156,971 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Amy Rosenbaum for performance year 2024, reported as part of a group. Amy Rosenbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Amy Rosenbaum as offering telehealth.